rs863224148
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PM6PP3PP4
This summary comes from the ClinGen Evidence Repository: The c.214C>T (p.R72C) variant in PDHA1 has been reported in multiples males with pyruvate dehydrogenase deficiency with phenotypes ranging from childhood onset Leigh syndrome spectrum (PMID:8664900) to living into adulthood with ataxia, neuropathy, and dystonia (PMID:21914562). We did not come across any affected female case reports in this extensive literature review. This variant has been reported to be inherited from a healthy mother (PMID:10679936; case 3-4) and there have been several de novo case reports, as well. Indeed, this variant has been identified as a de novo occurrence (unconfirmed parental relationships) in at least three unrelated individuals with pyruvate dehydrogenase deficiency [PM6; Utilized ClinGen SVI de novo scoring guidance (phenotype consistent but not highly specific); PMID:10679936, case 3-2; PMID:10679936, case 3-3; PMID:21914562, case AM23]. Additionally, this variant has been seen in at least one other individual with documented decreased pyruvate dehydrogenase activity (PP4; Patient 3 in PMID:15384102 had Leigh syndrome and decreased total PDH complex activity (in native and DCA-activated states) in fibroblast cell line (<3rd percentile of controls). This variant is absent from gnomAD v2.1.1 (PM2). The computational predictor REVEL gives a score of 0.955, which is above the threshold of 0.75, evidence that correlates with impact to PDHA1 function (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for pyruvate dehydrogenase deficiency inherited in an X-linked manner. This classification was approved by the NICHD U24 Mitochondrial Disease Variant Curation Expert Panel on May 20, 2020. PDHA1-specific ACMG/AMP criteria applied: PM2, PM6, PP3, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA320653/MONDO:0019169/014
Frequency
Consequence
NM_000284.4 missense
Scores
Clinical Significance
Conservation
Publications
- pyruvate dehydrogenase E1-alpha deficiencyInheritance: AR, XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000284.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | MANE Select | c.214C>T | p.Arg72Cys | missense | Exon 3 of 11 | NP_000275.1 | P08559-1 | ||
| PDHA1 | c.328C>T | p.Arg110Cys | missense | Exon 4 of 12 | NP_001166925.1 | P08559-4 | |||
| PDHA1 | c.214C>T | p.Arg72Cys | missense | Exon 3 of 11 | NP_001166926.1 | P08559-2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | TSL:1 MANE Select | c.214C>T | p.Arg72Cys | missense | Exon 3 of 11 | ENSP00000394382.2 | P08559-1 | ||
| PDHA1 | c.412C>T | p.Arg138Cys | missense | Exon 5 of 13 | ENSP00000617626.1 | ||||
| PDHA1 | c.328C>T | p.Arg110Cys | missense | Exon 4 of 12 | ENSP00000617636.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at